Results 1 to 10 of about 5,805 (130)
Frances Ashcroft +2 more
exaly +3 more sources
Pharmaco-topology of Sulfonylurea Receptors [PDF]
Joseph Bryan +2 more
exaly +2 more sources
Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor γ Activity and on Glucose Uptake by Thiazolidinediones [PDF]
BackgroundSulfonylurea primarily stimulates insulin secretion by binding to its receptor on the pancreatic β-cells. Recent studies have suggested that sulfonylureas induce insulin sensitivity through peroxisome proliferator-activated receptor γ (PPARγ ...
Kyeong Won Lee +5 more
doaj +1 more source
Background. The purpose was to investigate the effect of therapy with glucagon-like peptide-1 receptor agonists (GLP-1ra) on the serum concentration of trimethylamine-N-oxide (TMAO), an intestinal microbiome metabolite, in patients with type 2 diabetes ...
K.O. Shyshkan-Shyshova +4 more
doaj +1 more source
Type 2 diabetes therapy at the time of diagnosis. Glimepiride: property, efficiency, safety
В клинической практике имеется эффективный сахароснижающий препарат Амарил, обеспечивающий хороший контроль гликемии при однократном приеме, способствующий снижению массы тела, не имеющий побочных действий, обладающий экстрапанкреатическим ...
Olga Mikhailovna Smirnova
doaj +1 more source
An endogenous ligand for the central sulfonylurea receptor [PDF]
An endogenous ligand for the rat central sulfonylurea receptor has been evidenced in the rat central nervous system. The characteristics of this ligand (extractibility, non‐dialysability, chromatographic behaviour on different media, sensitivity to proteases) indicate that it is a neutral to slightly basic peptide.
Virsolvy-Vergine, A. +5 more
openaire +2 more sources
Transmembrane Topology of the Sulfonylurea Receptor SUR1 [PDF]
Sulfonylurea receptors (SURx) are multi-spanning transmembrane proteins of the ATP-binding cassette (ABC) family, which associate with Kir6.x to form ATP-sensitive potassium channels. Two models, with 13-17 transmembrane segments, have been proposed for SURx topologies.
L R, Conti +3 more
openaire +2 more sources
Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
Type 2 diabetes is believed to develop as a result of lowered insulin secretion and insulin resistance leading to hyperglycemia. Sulfonylureas stimulateinsulin secretion and thereby decrease blood glucose level which accounts for their wide application ...
Tatiana Ivanovna Romantsova +1 more
doaj +1 more source
The mechanism of the hypoglycaemic action of sulfonylurea agents remains controversial, in spite of the fact that they have been widely used in the clinical management of patients with NIDDM. in this study, we used insulin clearance and euglycaemic clamp
Ahmet Gökhan Özgen +7 more
doaj +2 more sources

